Get 40% Off
🔥 This hedge fund gained 26.16% in the last month. Get their top stocks with our free stock ideas tool.See stock ideas

U.S. exceeds 400,000 coronavirus deaths

Published 01/19/2021, 03:13 PM
Updated 01/19/2021, 04:25 PM
© Reuters. FILE PHOTO: El Paso County Medical Examiner's Office staff move bodies in El Paso
MRNA
-

By Anurag Maan and Roshan Abraham

(Reuters) - The U.S. coronavirus death toll topped 400,000 on Tuesday, according to a Reuters tally, as the country hardest hit by the pandemic struggled to meet the demand for vaccines to stem the spread of infection.

States including Michigan, New Jersey, New York, Oregon, South Carolina and Vermont have shown signs of vaccine supply strain and are asking for more doses of both approved vaccines, one from Pfizer-BioNTech and the other from Moderna (NASDAQ:MRNA).

The number of deaths has spiked since Christmas.

During the past three weeks, U.S. coronavirus fatalities have totaled 63,793 compared with 52,715 deaths in the three weeks prior to Christmas, an increase of 21%, according to a Reuters analysis.

The daily COVID-19 death numbers crossed 4,000 for the first time on Jan. 6.

Eighteen U.S. states, including California, Pennsylvania, Texas and Washington reported their highest daily death numbers in January, according to the Reuters tally.

The number of coronavirus cases has risen across all U.S. regions and on Tuesday crossed 24 million since the pandemic started.

While seriously ill patients are straining healthcare systems in parts of the country, especially in California, the national rate of hospitalizations has leveled off in the past two weeks and was near 124,000 on Tuesday.

President-elect Joe Biden, due to be sworn in on Wednesday, has proposed a $1.9 trillion aid package that includes $415 billion to bolster the response to the virus and the rollout of COVID-19 vaccines, some $1 trillion in direct relief to households, and roughly $440 billion for small businesses and communities hardest hit by the pandemic.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

(Graphic for U.S. COVID-19 death toll crosses 400,000: https://graphics.reuters.com/HEALTH-CORONAVIRUS/rlgpdglrqvo/chart.png)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.